NVAX Jan 2024 17.500 put
| Previous close | 10.30 |
| Open | 10.20 |
| Bid | 0.00 |
| Ask | 0.00 |
| Strike | 17.50 |
| Expiry date | 2024-01-19 |
| Day's range | 10.20 - 10.30 |
| Contract range | N/A |
| Volume | |
| Open interest | 210 |
Motley FoolDoes This Message From Moderna Mean Bad News for Novavax?
Moderna (NASDAQ: MRNA) recently gave an update on its pipeline and future goals, and the biotech had a lot to say. This doesn't mean Moderna is forgetting about the coronavirus vaccine though. In fact, this market giant announced something that could impact smaller rival Novavax (NASDAQ: NVAX).
- Investing.com
Novavax and Invitae implement cost-cutting measures amid financial challenges
In the volatile world of stock trading, healthcare companies Novavax (NASDAQ:NVAX) and Invitae (NYSE:NVTA) have been making headlines as they navigate significant financial challenges. Both firms are taking measures to reduce costs, aiming to improve their financial standing and appeal to a broader range of investors.
ZacksModerna (MRNA) Receives CHMP Nod for Updated COVID Vaccine
Clinical data from studies on Moderna's (MRNA) updated COVID vaccine shows improved antibody responses against multiple circulating variants, including BA.2.86, EG.5 and FL.1.5.1 variants.
